PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
October 1, 2000Heart38 citationsOpen Access

Reduction in Fas/APO-1 plasma concentrations correlates with improvement in left ventricular function in patients with idiopathic dilated cardiomyopathy treated with pentoxifylline

DSDaniel Skudicky

Structured PICO

Does pentoxifylline improve left ventricular function and reduce Fas/APO-1 plasma concentrations in patients with idiopathic dilated cardiomyopathy?

P
Population
patients with idiopathic dilated cardiomyopathy
I
Intervention
pentoxifylline
O
Outcome
Reduction in Fas/APO-1 plasma concentrations and improvement in left ventricular functionsurrogate

In patients with idiopathic dilated cardiomyopathy treated with pentoxifylline, a reduction in Fas/APO-1 plasma concentrations correlates with improved left ventricular function.

Abstract

Reduction in Fas/APO-1 plasma concentrations correlates with improvement in left ventricular function in patients with idiopathic dilated cardiomyopathy treated with pentoxifylline

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Daniel Skudicky (2000) studied this question.

synapsesocial.com/papers/6a8c0f28c12eaf65c8b22cf2https://doi.org/10.1136/heart.84.4.438
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Effect of Pentoxifylline on Apoptosis of Cultured Cells1995 · 35 citations
  2. 2Ventricular dilatation in the absence of ACE inhibitors: influence of haemodynamic and neurohormonal variables following myocardial infarction1999 · 6 citations
  3. 3Apoptosis in Myocytes in End-Stage Heart Failure1996 · 1,450 citations
  4. 4Antiarrhythmics—from cell to clinic: past, present, and future2000 · 35 citations
  5. 5TNF-induced cardiomyopathy1990 · 186 citations